Advertisement

Cardinal Health's drug sales boost overall revenue in Q3

By Michael Sandler  |  April 28, 2016

Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.

Andrew Bindman named director at AHRQ

By Michael Sandler  |  April 28, 2016

Dr. Andrew Bindman has been named director of the Agency for Healthcare Research and Quality, effective May 2. Sharon Arnold has served as acting director since March, when Richard Kronick stepped down. Kronick had led AHRQ, a division of HHS, since August 2013.

Abbott to spend $19.3B to buy St. Jude Medical

By Associated Press  |  April 28, 2016

Abbott Laboratories will spend $19.3 billion to buy St. Jude Medical in a cash-stock deal that aims to strengthen the medical-device maker's share of the market for cardiovascular care.

Aetna loses membership in Q1 but builds revenue

By Bob Herman  |  April 28, 2016

Aetna's total medical membership fell by almost a half million people since the start of the year, but the Hartford, Conn.-based health insurer was still able to build revenue.

Michigan system to appeal hospital's Medicare termination

By Jay Greene, Crain's Detroit Business  |  April 28, 2016

Officials for St. John Providence Health System in eastern Michigan say they will appeal a letter terminating Medicare participation for one of its hospitals, effective May 7. The April 14 notification by CMS was over a patient who committed suicide at St. John River District Hospital in St. Clair.

Sanofi makes $9.3 billion bid for Medivation

By Associated Press  |  April 28, 2016

Drugmaker Sanofi says it has made a $9.3 billion bid for San Francisco pharmaceutical firm Medivation, part of the firm's effort to expand its portfolio of cancer treatments.

Shareholders criticize Pfizer over scrapped Allergan deal

By Associated Press  |  April 28, 2016

Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to Ireland, company executives faced sharp criticism from shareholders at their annual meeting.

Will Medicare's physician payment overhaul drive more docs to hospitals?

By Beth Kutscher and Adam Rubenfire  |  April 27, 2016

The CMS has started to answer the many questions surrounding how physicians will get paid under the Medicare Access and CHIP Reauthorization Act. But some stakeholders were immediately dissatisfied with what they saw, and the 963-page rule may have raised as many questions as it answered.

The striking variation of commercial healthcare prices

By Bob Herman  |  April 27, 2016

One of the most comprehensive, independent studies of commercial healthcare prices shows that employers and insurers that provide private health coverage pay a lot more for services depending on the state where people live.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.